Vical, Inc. (VICL) Reports In-Line Q2 Loss; Revs Light
Tweet
Share
E-mailGet Alerts VICL Hot Sheet
Price: $0.68 --0%
Financial Fact:
Loss from operations: -2.57M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Loss from operations: -2.57M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Vical, Inc. (NASDAQ: VICL) reported Q2 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $820 thousand versus the consensus estimate of $1.61 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Intuitive Machines, Inc. (LUNR) Misses Q2 EPS by 20c, Misses on Revenue; Offers FY26 Revenue Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
